CellSeed
Basic Information
- Stock Code
- 7776
- Industry
- Precision Instruments
- Category Detail
- Biotechnology & Pharmaceuticals
- Prefecture
- Tokyo
- Establishment Year
- May 2001
- Listing Year
- March 2010
- Official Website
- https://www.cellseed.com/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- GNI Group, Heartseed, Nexela Pharma, Peptidream, SanBio, Helios, Perseus, RenaScience, QualiPs, K Pharma, Takara Bio, Japan Tissue Engineering
Overview
CellSeed is a biotech venture established in 2001, a cutting-edge medical company with proprietary technology in the precision instruments field, centered on cell sheet regenerative medicine business.
Current Situation
CellSeed has recently focused on regenerative medicine business utilizing cell sheets, and while small-scale, it holds competitiveness in medical cell sheet development. In 2022, it transitioned to the Tokyo Stock Exchange Growth Market, activating fundraising and research and development. Financially, sales are around 100 million yen, small-scale but expanding regenerative medicine support business and joint research, advancing new technology development. Overseas, it holds multiple related companies in Europe and is engaged in international clinical research collaborations. Competitors include multiple companies in the bio-pharmaceutical sector, with the speed of technology development and unique smart polymer technology serving as differentiating factors. There have been reports of insider trading suspicions, making governance strengthening a challenge. In the future, it aims for sustainable growth by capturing expansion in the regenerative medicine field and rising market needs. Technologically, it continues collaborative research with universities and others, promoting new product development. It is also strengthening environmental and social initiatives to enhance corporate value.
Trivia
Interesting Facts
- Grown as a biotech venture established in 2001.
- Leading company in developing cell sheets for esophageal function regeneration.
- Pioneering developer of smart polymer technology.
- Conducts collaborative research with Tokyo Women's Medical University and Waseda University.
- Listed on TSE Growth Market with a lean elite organization.
- Strengthening governance following insider trading suspicion reports.
- Established multiple European affiliates to promote international expansion.
- Featured on Nikkei Special 'Gaias no Yoake'.
- Holds numerous domestic and international patents for cell sheet technology.
- Aims to commercialize cutting-edge technologies in regenerative medicine.
Hidden Connections
- Close joint research framework with Japan Tissue Engineering.
- Utilizes collaborative research bases with Tokyo Women's Medical University and Waseda University.
- Participates in international clinical research through European affiliates.
- Affected by STAP cell research scandal in stock price.
- Verifying application possibilities of smart polymer technology beyond medicine.
- Research and development group with diverse technicians despite small numbers.
- Securities supervisory authorities monitoring due to insider trading suspicions.
- Advancing strengthened partnerships with European medical companies as shareholders.
Future Outlook
Growth Drivers
- Sustained expansion trend in regenerative medicine market.
- Expansion of applications for smart polymer and other material technologies.
- Accelerated research through deepened collaborations with universities and medical institutions.
- Promotion of international regulatory easing and clinical deployment in regenerative medicine.
- Government regenerative medicine promotion policies and expanded subsidies.
- Increasing demand for specialized technologies due to advancing patient needs.
- Growth in overseas business centered on Europe.
- Improved product reliability through accumulated clinical data.
- Rapid R&D processes using AI.
- Promotion of open innovation in life sciences field.
Strategic Goals
- Expansion of market share for cell sheet regenerative medicine products.
- Realization of multifaceted applications for smart polymer technology.
- Achievement of over 30% overseas sales ratio.
- Globalization of clinical research collaboration network.
- Strengthening governance and enhancing CSR activities.
- Building sustainable research and development system.
- Continuous acquisition of new medical technology-related patents.
- Diversification and high value-added enhancement of product lineup.
- Establishment of brand as industry leader.
- Ensuring long-term financial soundness.
Business Segments
Products for Regenerative Medicine-Related Companies
- Overview
- Provides advanced cell sheet technology to regenerative medicine companies and research institutions.
- Competitiveness
- Proprietary product lineup based on patented technology and university collaborative research
- Customers
-
- Biopharmaceutical Manufacturers
- Regenerative Medicine Ventures
- University Research Institutions
- Clinical Research Institutions
- Products
-
- Cell Sheets
- Smart Polymer Materials
- Regenerative Medicine Support Solutions
Cell Sheet Solutions for Medical Institutions
- Overview
- Provides cell sheets used in medical settings to support clinical regenerative medicine.
- Competitiveness
- Proven high-function cell sheet technology and specialized support system
- Customers
-
- University Hospitals
- Specialty Clinics
- Advanced Medical Facilities
- Products
-
- Esophageal Regeneration Cell Sheet
- Corneal Regeneration Cell Sheet
Reagents and Materials Sales for Research Institutions
- Overview
- Provides high-quality materials and technical support necessary for research and development.
- Competitiveness
- Material development capabilities specialized in regenerative medicine
- Customers
-
- University Labs
- Pharmaceutical Company R&D Departments
- Bio-Related Startups
- Products
-
- Smart Polymer Specialized Materials
- Cell Culture Consumables
Competitive Advantage
Strengths
- Cell sheet development capabilities through proprietary technology
- Strong research collaborations with universities
- Specialization focused on regenerative medicine
- International clinical research network
- Advanced smart polymer technology
- Agile R&D organization despite small scale
- International expansion with overseas affiliates
- Rich patent portfolio
- Diversification of regenerative medicine support services
- Credibility from listing on JASDAQ Growth Market
Competitive Advantages
- Strength in specific regenerative medicine applications with proprietary cell sheet technology
- Product differentiation through smart polymer material development
- Rapid commercialization of cutting-edge research through university collaborations
- Highly specialized development team despite small scale
- International expansion centered on Europe
- Ability to meet diverse customer needs through regenerative medicine support business
- Entry barriers for competitors formed by technology patents
- High-value-added product development utilizing proprietary research成果
- Practical product design through collaborations with clinical sites
- Ongoing fundraising capabilities financially
Threats
- Intensifying competition with large bio companies
- Risk of product development delays due to stricter regulations
- Decline in credibility from insider trading suspicions
- Fluctuations in research funding environment
- Uncertainty in product approvals
- Legal risks such as patent litigation
- Obsolescence due to rapid advancement of new technologies
- Market need fluctuations and emergence of competing technologies
- Acceleration of new entrant startups
- Impact on overseas business from international political risks
Innovations
2022: Transition to Tokyo Stock Exchange Growth Market
- Overview
- Shifted market segment to TSE Growth Market, strengthening fundraising environment.
- Impact
- Contributes to improved capital liquidity and increased corporate value
2021: Joint Research with Japan Tissue Engineering
- Overview
- Continued joint research contract to expand applications of cell sheet technology.
- Impact
- Accelerates new product development and strengthens clinical research
2023: Development of New Smart Polymer Material
- Overview
- Succeeded in improving innovative temperature-responsive polymer.
- Impact
- Contributes to quality improvement in cell sheet technology
Sustainability
- Promoting energy-saving measures in research facilities
- Enhancing safety of regenerative medicine products
- Social collaboration activities with local medical institutions
- Workplace diversity and labor environment improvements
- Building a long-term research and development system